LCM
ORIC icon

Legato Capital Management’s Oric Pharmaceuticals ORIC Stock Holding History

Legato Capital Management’s Portfolio ORIC Stock Details ORIC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-23,396
Closed -$281K – 806
2025
Q3 		$281K Buy
+23,396
New +$246K 0.03% 494
2025
Q2 		– Sell
-19,523
Closed -$109K – 603
2025
Q1 		$109K Buy
+19,523
New +$171K 0.01% 528
2024
Q2 		– Sell
-23,100
Closed -$318K – 612
2024
Q1 		$318K Buy
+23,100
New +$274K 0.04% 501

Other funds holding ORIC

NI
Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
P
Pfizer New York $239M AUM 232.47% 1-Year Est. Return
SOCM
SR One Capital Management Wayne, Pennsylvania $915M AUM 209.71% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Alkeon Capital Management
Alkeon Capital Management New York $59.5B AUM 51.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Legato Capital Management's ORIC Position: Q4 2025 in Review

Legato Capital Management sold out of Oric Pharmaceuticals (ORIC) in Q4 2025, closing a stake of 23,396 shares — an estimated $281K sold.

Legato Capital Management first reported a position in ORIC in Q1 2024 and held it in 3 quarters. The position peaked at $318K in Q1 2024. 164 funds tracked by Wall St. Rank hold ORIC as of Q4 2025.

  • Legato Capital Management reported no remaining Oric Pharmaceuticals position as of Q4 2025 after selling out during the quarter.
  • Legato Capital Management sold 23,396 Oric Pharmaceuticals shares in Q4 2025, an estimated $281K.
  • Legato Capital Management first reported a position in Oric Pharmaceuticals in Q1 2024 and held it in 3 quarters.
  • Legato Capital Management's Oric Pharmaceuticals position peaked at $318K in Q1 2024.
  • 164 funds tracked by Wall St. Rank held Oric Pharmaceuticals as of Q4 2025.

Based on Legato Capital Management's 13F filing for Q4 2025, filed 6 Feb 2026.